Skip to main content
. 2019 Oct 16;6(5):ENEURO.0165-19.2019. doi: 10.1523/ENEURO.0165-19.2019

Figure 4.

Figure 4.

The mitigating effect of proBDNF on SD-induced deficits in acquisition of fear extinction required NR2B subunit of NMDA receptors. A, Treatment procedure. Conditioned rats received post-SD infusion(s) and then tested 48 h following contextual conditioning. B, The effect of proBDNF, mBDNF, and anti-proBDNF antibody on SD-induced extinction impairment; ***p < 0.001: SD or CON-Anti versus CON or SD-proBDNF; ##p < 0.01, ###p < 0.001: SD-mBDNF versus CON or SD-proBDNF; %%p < 0.01: SD-mBDNF versus SD or CON-Anti; n = 7 per group. C, Rats were subjected SD between ZT0 and ZT4, the effect of co-infusion NMDA receptor antigonists (CPP, NVP, and Ro25) and proBDNF on freezing levels were tested; ***p < 0.001: Sal-proBDNF versus Sal-Sal, CPP-proBDNF or Ro25-proBDNF; ##p < 0.01, ###p < 0.001: NVP-proBDNF versus Sal-Sal, CPP-proBDNF or Ro25-proBDNF; n = 8 per group. D, The proBDNF levels of SD rats that treated with proBDNF and mBDNF throughout the circadian cycle; ***p < 0.001: SD versus CON or SD-proBDNF; ##p < 0.01: SD-mBDNF versus CON or SD-proBDNF; %p < 0.05: SD-mBDNF versus SD; n = 6 per time point.